Exact Mass: 399.1806

Thiethylperazine

C22H29N3S2 (399.1803)

A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457) R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Thiethylperazine, a phenothiazine derivate, is an orally active and potent dopamine D2-receptor and histamine H1-receptor antagonist. Thiethylperazine is also a selective ABCC1activator that reduces amyloid-β (Aβ) load in mice. Thiethylperazine has anti-emetic, antipsychotic and antimicrobial effects[1][2][3].

Lenapenem

C18H29N3O5S (399.1828)

Mericitabine

C18H26FN3O6 (399.1806)

Propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate

C23H29NO3S (399.1868)

31F508b2

C21H25N3O5 (399.1794)

3beta-hydroxylissoclimide

C20H30ClNO5 (399.1812)

(-)-protubonine B|11-epi-protubonine B|protubonine B

C21H25N3O5 (399.1794)

Ser Phe Phe

C21H25N3O5 (399.1794)

Phe Tyr Ala

C21H25N3O5 (399.1794)

Ala Tyr Phe

C21H25N3O5 (399.1794)

Phe Ser Phe

C21H25N3O5 (399.1794)

Phe Phe Ser

C21H25N3O5 (399.1794)

Ala Phe Tyr

C21H25N3O5 (399.1794)

ACMC-20li7n

C21H25N3O5 (399.1794)

Tyr Ala Phe

C21H25N3O5 (399.1794)

thiethylperazine

C22H29N3S2 (399.1803)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Thiethylperazine, a phenothiazine derivate, is an orally active and potent dopamine D2-receptor and histamine H1-receptor antagonist. Thiethylperazine is also a selective ABCC1activator that reduces amyloid-β (Aβ) load in mice. Thiethylperazine has anti-emetic, antipsychotic and antimicrobial effects[1][2][3].

Phe Ala Tyr

C21H25N3O5 (399.1794)

Tyr Phe Ala

C21H25N3O5 (399.1794)

Diethylpropion (metabolite VII Glucuronide)

C19H29NO8 (399.1893)

JWH 210 N-(5-carboxypentyl) metabolite

C26H25NO3 (399.1834)

Ansoxetine

C26H25NO3 (399.1834)

(2R)-2-BOC-AMINO-3-PHENYLSULFONYL-1-(2-TETRAHYDROPYRANYLOXY)PROPANE

C19H29NO6S (399.1715)

6-(Diethylamino)-1,3-dimethylfluoran

C26H25NO3 (399.1834)

AzocarmineG2

C28H21N3 (399.1735)

sodium hydrogen (R)-12-(sulphonatooxy)oleate

C18H32NaO6S (399.1817)

(S)-4-(8-amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

C22H21N7O (399.1807)

1,1,2-Pentanetricarboxylic acid, 4-methyl-, 1,1-bis(phenylmethyl) ester (9CI)

C23H27O6 (399.1808)

N-(2-Amino-ethyl)-2-(benzyl-phenyl-amino)-acetamide maleate

C21H25N3O5 (399.1794)

Mericitabine

C18H26FN3O6 (399.1806)

C254 - Anti-Infective Agent > C281 - Antiviral Agent

3-fluoro-4-[[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)acetyl]amino]benzoic acid

C23H26FNO4 (399.1846)

Bucindolol hydrochloride

C22H26ClN3O2 (399.1713)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate

C23H29NO3S (399.1868)

D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists MRS 1523 is a potent and selective adenosine A3 receptor antagonist with Ki values of 18.9 nM and 113 nM for human and rat A3 receptors, respectively. In rat this corresponds to selectivities of 140- and 18-fold vs A1 and A2A receptors, respectively. MRS 1523 can exert antihyperalgesic effect through N-type Ca channel block and action potential inhibition in isolated rat dorsal root ganglion (DRG) neurons[1][2].

l-Tyrosyl-l-alanyl-l-phenylalanine

C21H25N3O5 (399.1794)

3-Fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-YL)-acetylamino]-benzoic acid

C23H26FNO4 (399.1846)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

N-benzoyl-D-argininium-4-nitroanilide(1+)

C19H23N6O4+ (399.1781)

(2E,4E,6Z)-8-oxo-8-[(1S,2R,11R)-1,2,5-trimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-11-yl]oxyocta-2,4,6-trienoate

C23H27O6- (399.1808)

Protubonine B

C21H25N3O5 (399.1794)

An acetate ester obtained by the formal condensation of the hydroxy group of the fungal metabolite protubonine A with acetic acid. It has been isolated from Aspergillus species. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

3-(3-Chloro-4-methoxyphenyl)-1-(2-methoxyethyl)-1-(1-propan-2-yl-4-piperidinyl)thiourea

C19H30ClN3O2S (399.1747)

N-[2,5-dimethoxy-4-[[2-(4-morpholinyl)-1-oxoethyl]amino]phenyl]benzamide

C21H25N3O5 (399.1794)

N-(3-chloro-4-methylphenyl)-2-[3-(5-methyl-2-tetrazolyl)-1-adamantyl]acetamide

C21H26ClN5O (399.1826)

Onetine

C19H29NO8 (399.1893)

A pyrrolizine alkaloid that is produced by a hybrid species of Jacobaea.

Ala-Phe-Tyr

C21H25N3O5 (399.1794)

Phe-Phe-Ser

C21H25N3O5 (399.1794)

Phe-Tyr-Ala

C21H25N3O5 (399.1794)

Ser-Phe-Phe

C21H25N3O5 (399.1794)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

[(1S)-1-[(2,5-difluorophenyl)methyl]-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C22H23F2N3O2 (399.1758)

N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C18H29N3O5S (399.1828)

Tyr-Phe-Ala

C21H25N3O5 (399.1794)

Ala-Tyr-Phe

C21H25N3O5 (399.1794)

Phe-Ala-Tyr

C21H25N3O5 (399.1794)

Phe-Ser-Phe

C21H25N3O5 (399.1794)

(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C18H29N3O5S (399.1828)

Tyr-Ala-Phe

C21H25N3O5 (399.1794)

(1ar,2s,7bs)-7-{[(2r)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-2-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-1h,1ah,2h,7bh-3λ⁵-cyclopropa[a]indolizin-3-ylium

[C22H27N2O3S]+ (399.1742)

(19s,21s)-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

C21H25N3O5 (399.1794)

9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

C21H25N3O5 (399.1794)

(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7(12),9-diene-8,11-dione

C21H25N3O5 (399.1794)

7-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-2-(5-methylhepta-1,3,5-trien-1-yl)-1h,1ah,2h,7bh-3λ⁵-cyclopropa[a]indolizin-3-ylium

[C22H27N2O3S]+ (399.1742)

(1r,4s,7r,9r)-16-acetyl-6-hydroxy-4-(2-methylpropyl)-3-oxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-9-yl acetate

C21H25N3O5 (399.1794)

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-7-chloro-3,6-dihydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H30ClNO5 (399.1812)

3-[2-(7-chloro-3,6-dihydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H30ClNO5 (399.1812)

16-acetyl-6-hydroxy-4-(2-methylpropyl)-3-oxo-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-9-yl acetate

C21H25N3O5 (399.1794)